Pure Biologics Spólka Akcyjna
PUR.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Gross Profit | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| % Margin | – | – | – | – |
| R&D Expenses | PLN 1 | PLN 2 | PLN 0 | PLN 0 |
| G&A Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 1 |
| SG&A Expenses | PLN 0 | PLN 3 | PLN 0 | PLN 1 |
| Sales & Mktg Exp. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Operating Expenses | -PLN 0 | -PLN 3 | PLN 0 | PLN 5 |
| Operating Expenses | PLN 1 | PLN 3 | PLN 1 | PLN 7 |
| Operating Income | -PLN 1 | -PLN 3 | -PLN 1 | -PLN 7 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| Pre-Tax Income | -PLN 1 | -PLN 3 | -PLN 1 | -PLN 7 |
| Tax Expense | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Net Income | -PLN 1 | -PLN 5 | -PLN 1 | -PLN 11 |
| % Margin | – | – | – | – |
| EPS | -0.21 | -0.74 | -0.34 | -1.94 |
| % Growth | 71.6% | -117.6% | 82.5% | – |
| EPS Diluted | -0.21 | -0.74 | -0.34 | -1.94 |
| Weighted Avg Shares Out | 6 | 6 | 5 | 6 |
| Weighted Avg Shares Out Dil | 8 | 4 | 4 | 4 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Interest Expense | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Depreciation & Amortization | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| EBITDA | -PLN 1 | -PLN 2 | -PLN 1 | -PLN 7 |
| % Margin | – | – | – | – |